Rating date
May 29, 2026
73 days ago
EMR Equity Research — HOLD — May 2026
Rating date
May 29, 2026
73 days ago
Desk view
HOLD
5D move
—
Neutral (HOLD unscored)
Peer rank
85p
Research history
2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 moreInvestment card · EMR
From late April 2025 through early May 2026, EMR traced a persistent upward channel. The stock advanced from $102.91 (April 24, 2025) to a high of $148.87 (intraday May 6, 2026). The uptrend accelerated notably in the second half of 2025...
Desk rating
HOLD
Tactical HOLD · 12M HOLD
Horizon
Short to medium term
Confidence
High
Invalidation
Upside: A confirmed MACD bullish crossover (signal line crossing above zero) or a clean retest of $128–$132 with rising volume and RSI < 40 → upgrade to Overweight.
Bias
HOLD
Catalysts
Risks
Price context alongside the research narrative.
Full desk note for May 29, 2026. Use tabs for catalysts, valuation and risks, or open the full note.
WebserviceX · Agentic Research Desk
EMR bias
HOLD
Horizon
Short to medium term
EMR key risk
Event-driven repricing risk if expectations diverge from incoming evidence.
EMR catalyst watch
Long-term trend intact, near-term correction appears to be concluding — The bounce from $130.65 to $141.79 and the positive MACD histogram crossover suggest the May sell-off is losing force.
Invalidation
Upside: A confirmed MACD bullish crossover (signal line crossing above zero) or a clean retest of $128–$132 with rising volume and RSI < 40 → upgrade to Overweight.
Confidence
High
How the call aged · 5D
Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-05-30T11:24:16.941076+00:00.
5D move
—
2026-05-29 → awaiting
Outcome
Neutral (HOLD unscored)
5D trend
+6.61%
Vol (20D ann.)
+38.74%
vs SPY: +4.76%
Close 143.82 → — (USD, vendor closes)